Digital Therapeutics and the Future of Mental Health Management
We are empowering patients and doctors to make better choices sooner.
The Digital Therapeutics Alliance defines digital therapeutics (DTx) as “evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease”.
The Common Traits of Digital Therapeutics
Data collection and Active Management
Digital Therapeutics collect disorder-specific health data, visualize them and actively support patients and doctors to manage these health conditions.
Development of digital therapeutics applications must undergo rigorous clinical studies proving the effects on specific disorders and health conditions. This process includes thousands of hours of clinical observations, analysis and peer review of results.
Supported by Medical Professionals
Given the high efficiency of these applications, and proof from clinical studies, the use of digital therapeutics apps is generally supported by medical professionals. Many digital therapeutics also follow the patient-doctor-carer co-management methodology.
Covered by Insurance
Due to their proven efficiency and low risks, many health insurance companies are covering the cost of digital therapeutics software and hardware for their patients. In many cases, digital therapeutics have proven to be a great complement to conventional medicine.
Controlled by Leading Health Authorities (i.e., FDA)
Digital therapeutics are tightly controlled by the FDA (Food and Drug Administration) in the US and similar organizations worldwide. This control ensures high efficiency and a very low risk of adverse effects.